facebook
twitter

facebook
twitter

Medical Dialogues
Speciality Dialogues
Education Dialogues
Medical Jobs
Medical Matrimony
MD Brand Connect

News
blog

Home
News
blog

Home
abbreviated new drug...

Tag: abbreviated new drug application

You Searched For "abbreviated new drug application"

Panacea Biotec gets USFDA nod to file for generic cancer drug

Panacea Biotec gets USFDA nod to file for generic cancer drug

Ruby Khatun Khatun2 Dec 2017 4:30 AM GMT

New Delhi: Panacea Biotec said the US health regulator has accepted its filing for approval of generic version of cancer treatment injection...

Cipla gets USFDA nod for generic version of Renvela tablets

Cipla gets USFDA nod for generic version of Renvela tablets

supriya kashyap kashyap28 Oct 2017 3:48 AM GMT

New Delhi: Drug major Cipla said its subsidiary InvaGen Pharmaceuticals Inc has received final approval from the US health regulator for Sevelamer...

Cadila Healthcare beats Lupin to become 2nd most valued pharma company in India

Cadila Healthcare beats Lupin to become 2nd most valued pharma company in India

Ruby Khatun Khatun8 Jun 2017 8:56 AM GMT

New Delhi: Shares of Cadila Healthcare surged nearly 10 per cent, helping the company overtake Lupin to become the second most valued pharma firm in...

Ajanta Pharma gets USFDA nod for Aripiprazole Tablets

Ajanta Pharma gets USFDA nod for Aripiprazole Tablets

savita thakur thakur15 Sep 2016 7:03 AM GMT

Ajanta Pharma Limited announces the receipt of final approval for Aripiprazole Tablets (2mg, 5mg, 10mg, 15mg, 20mg, 30mg), the bio equivalent generic...

Popular Stories

• Email: info@medicaldialogues.in
• Phone: 011 - 4372 0751

Website Last Updated On : 13 Oct 2022 5:14 AM GMT

Company

About Us
Contact Us
Our Team
Reach our Editor
Feedback
Submit Article

Ads & Legal

Advertise
Advertise Policy
Terms and Conditions
Privacy Policy
Editorial Policy
Comments Policy
Disclamier

Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

© 2020 - Medical Dialogues. All Rights Reserved.

Powered By: Hocalwire

X